A membranous nephropathy variant mimicking minimal change disease
Abstract This study characterizes a novel disease pattern of membranous nephropathy (MN) that exhibits overlapping clinicopathological features with minimal change disease (MCD), termed ‘MCD‐like MN’. Patients with histologically confirmed MN showing sparse and segmental subepithelial electron‐dense deposits (EDD) but clinically resembling MCD were ...
Chuqi Pan +8 more
wiley +1 more source
Coexistence of SAPHO syndrome and IgG4-related disease with Upadacitinib. [PDF]
Zhou H +5 more
europepmc +1 more source
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen +2 more
wiley +1 more source
IgG4-Related Disease With Lung and Kidney Involvement: A Case Report. [PDF]
Sá Lima A +3 more
europepmc +1 more source
IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease [PDF]
R Motta, Emma Culver
openalex +1 more source
6/7 patients achieved CMI by the third follow‐up, sustained to the fourth follow‐up, and 4/6 reached MSE by the fifth follow‐up. First real‐world evidence of adding telitacicept efficacy in refractory ocular MG symptoms Abstract Introduction Refractory ocular myasthenia gravis (MG) represents a significant therapeutic challenge, as conventional ...
Jing Lin +4 more
wiley +1 more source
IgG4-related disease masquerading as malignancy in the abdomen: A diagnostic challenge. [PDF]
Rahmatullah ZF, Hruban RH, Fishman EK.
europepmc +1 more source
Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report
ABSTRACT Eosinophilic fasciitis (EF) is a rare condition with an unknown cause. This case study showed that a 40‐year‐old man with EF did not respond to standard treatments but improved after receiving rituximab and intravenous immunoglobulin (IVIG). Further studies are needed to confirm rituximab's effectiveness and long‐term safety for EF.
Maryam Sahebari +4 more
wiley +1 more source
Dual Malignancies in IgG4-Related Disease: A Diagnostic and Therapeutic Challenge. [PDF]
Li J, Zhang M, Song J, Zhang L, Li SG.
europepmc +1 more source
Coexistence of nontuberculous mycobacterium and IgG4-related disease in a solitary pulmonary nodule
Kyungsoo Bae +5 more
openalex +1 more source

